A
References

Althuis, M. D., K. S. Moghissi, C. L. Westhoff, B. Scoccia, E. J. Lamb, J. H. Lubin, and L. A. Brinton. 2005. Uterine cancer after use of clomiphene citrate to induce ovulation. American Journal of Epidemiology 161(7):607-615.

Barbarino-Monnier, P., B. Gobert, F. Guillet-Rosso, M. C. Bene, P. Landes, and G. Faure. 1991. Antiovary antibodies, repeated attempts, and outcome of in vitro fertilization. Fertility and Sterility 56(5):928-932.

Bellver, J., E. A. Muñoz, A. Ballesteros, S. R. Soares, E. Bosch, C. Simón, A. Pellicer, and J. Remohi. 2003. Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: A randomized controlled study. Human Reproduction 18(11):2283-2288.

Borten, M. 1980. Laparoscopic complications: Prevention and management. Philadelphia: BC Decker.

Brinton, L. A., B. Scoccia, K. S. Moghissi, C. L. Westhoff, M. D. Althuis, J. E. Mabie, and E. J. Lamb. 2004. Breast cancer risk associated with ovulation-stimulating drugs. Human Reproduction 19(9):2005-2013.

Budev, M. M., A. C. Arroliga, and T. Falcone. 2005. Ovarian hyperstimulation syndrome. Critical Care Medicine 33(10 Suppl): p. S301-S306.

Caligara, C., J. Navarro, G. Vargas, C. Simón, A. Pellicer, and J. Remohi. 2001. The effect of repeated controlled ovarian stimulation in donors. Human Reproduction 16(11):2320-2323.

CDC. Centers for Disease Control and Prevention. Assisted reproductive technology success rates. http://www.cdc.gov/ART/ART2003/index.htm (accessed December 22, 2006).

Coroleu, B., F. Lopez Mourelle, L. Hereter, A. Veiga, G. Calderón, F. Martinez, O. Carreras, and P. N. Barri. 1997. Ureteral lesion secondary to vaginal ultrasound follicular puncture for Oocyte recovery in in-vitro fertilization. Human Reproduction 12(5):948-950.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 61
Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report A References Althuis, M. D., K. S. Moghissi, C. L. Westhoff, B. Scoccia, E. J. Lamb, J. H. Lubin, and L. A. Brinton. 2005. Uterine cancer after use of clomiphene citrate to induce ovulation. American Journal of Epidemiology 161(7):607-615. Barbarino-Monnier, P., B. Gobert, F. Guillet-Rosso, M. C. Bene, P. Landes, and G. Faure. 1991. Antiovary antibodies, repeated attempts, and outcome of in vitro fertilization. Fertility and Sterility 56(5):928-932. Bellver, J., E. A. Muñoz, A. Ballesteros, S. R. Soares, E. Bosch, C. Simón, A. Pellicer, and J. Remohi. 2003. Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: A randomized controlled study. Human Reproduction 18(11):2283-2288. Borten, M. 1980. Laparoscopic complications: Prevention and management. Philadelphia: BC Decker. Brinton, L. A., B. Scoccia, K. S. Moghissi, C. L. Westhoff, M. D. Althuis, J. E. Mabie, and E. J. Lamb. 2004. Breast cancer risk associated with ovulation-stimulating drugs. Human Reproduction 19(9):2005-2013. Budev, M. M., A. C. Arroliga, and T. Falcone. 2005. Ovarian hyperstimulation syndrome. Critical Care Medicine 33(10 Suppl): p. S301-S306. Caligara, C., J. Navarro, G. Vargas, C. Simón, A. Pellicer, and J. Remohi. 2001. The effect of repeated controlled ovarian stimulation in donors. Human Reproduction 16(11):2320-2323. CDC. Centers for Disease Control and Prevention. Assisted reproductive technology success rates. http://www.cdc.gov/ART/ART2003/index.htm (accessed December 22, 2006). Coroleu, B., F. Lopez Mourelle, L. Hereter, A. Veiga, G. Calderón, F. Martinez, O. Carreras, and P. N. Barri. 1997. Ureteral lesion secondary to vaginal ultrasound follicular puncture for Oocyte recovery in in-vitro fertilization. Human Reproduction 12(5):948-950.

OCR for page 61
Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report de Boer, E. J., I. Den Tonkelaar, C. W. Burger, C. W. N. Looman, F. E. van Leeuwen, E. R. Velde, M. Kortman, N. Macklon, C. A. M. Jansen, R. A. Leerentveld, W. N. P. Willemsen, R. Schats, N. Naaktgeboren, F. M. Helmerhorst, R. S. G. M. Bots, A. H. M. Simons, H. V. Hogerzeil, J. L. H. Evers, and P. A. van Dop. 2004. The number of retrieved oocytes does not decrease during consecutive gonadotrophin-stimulated IVF cycles. Human Reproduction 19(4):899-904. Delvigne, A. and S. Rozenberg, Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum Reprod Update, 2002. 8(6): p.559-77. Dicker, D., J. Ashkenazi, D. Feldberg, T. Levy, A. Dekel, and Z. Ben-Rafael. 1993. Severe abdominal complications after transvaginal ultrasonographically guided retrieval of oocytes for in vitro fertilization and embryo transfer. Fertility and Sterility 59(6):1313-1315. Ditkoff, E. C., J. Plumb, A. Selick, and M. V. Sauer. 1997. Anesthesia practices in the United States common to in vitro fertilization (IVF) centers. Journal of Assisted Reproduction and Genetics 14(3):145-147. Elkington, N. M., J. Kehoe, and U. Acharya. 2003. Recommendations for good practice for sedation in assisted conception. Human Fertility 6(2):77-80. Fugita, O. E., and L. Kavoussi. 2001. Laparoscopic ureteral reimplantation for ureteral lesion secondary to transvaginal ultrasonography for oocyte retrieval. Urology 58(2):281i-281iii. Garcia-Velasco, J. A., V. Isaza, G. Quea, and A. Pellicer. 2006. Coasting for the prevention of ovarian hyperstimulation syndrome: Much ado about nothing? Fertility and Sterility 85(3):547-554. Gobert, B., P. Barbarino-Monnier, F. Guillet-May, M. C. Bene, and G. C. Faure. 1992. Anti-ovary antibodies after attempts at human in vitro fertilization induced by follicular puncture rather than hormonal stimulation. Journal of Reproduction and Fertility 96(1):213-218. Gorrill, M. J., L. K. Johnson, P. E. Patton, and K. A. Burry. 2001. Oocyte donor screening: The selection process and cost analysis. Fertility and Sterility 75(2):400-404. Govaerts, I., F. Devreker, A. Delbaere, P. Revelard, and Y. Englert. 1998. Short-term medical complications of 1500 oocyte retrievals for in vitro fertilization and embryo transfer. European Journal of Obstetrics Gynecology and Reproductive Biology 77(2):239-243. Greenfeld, D. A., C. M. Mazure, D. L. Olive, and D. L. Keefe. 1995. Similarities and differences between anonymous and directed candidates for oocyte donation. Journal of Assisted Reproduction and Genetics 12(2):118-122. Hall, V. J., D. Compton, P. Stojkovic, M. Nesbitt, M. Herbert, A. Murdoch, and M. Stojkovic. 2007. Developmental competence of human in vitro aged oocytes as host cells for nuclear transfer. Human Reproduction 22(1):52-62.

OCR for page 61
Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report Hohmann, F. P., N. S. Macklon, and B. C. J. M. Fauser. 2003. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol. Journal of Clinical Endocrinology and Metabolism 88(1):166-173. Jordan, C. B., C. D. Belar, and R. S. Williams. 2004. Anonymous oocyte donation: A follow-up analysis of donors’ experiences. Journal of Psychosomatic Obstetrics and Gynecology 25(2):145-151. Kalfoglou, A. L., and G. Geller. 2000. A follow-up study with oocyte donors exploring their experiences, knowledge, and attitudes about the use of their oocytes and the outcome of the donation. Fertility and Sterility 74(4):660-667. Kalfoglou, A. L., and J. Gittelsohn. 2000. A qualitative follow-up study of women’s experiences with oocyte donation. Human Reproduction 15(4):798-805. Kashyap, S., D. Moher, M. F. K. Fung, and Z. Rosenwaks. 2004. Assisted reproductive technology and the incidence of ovarian cancer: A meta-analysis. Obstetrics and Gynecology 103(4):785-794. Klemetti, R., T. Sevon, M. Gissler, and E. Hemminki. 2005. Complications of IVF and ovulation induction. Human Reproduction 20(12):3293-3300. Klock, S. C., A. M. Braverman, and D. T. Rausch. 1998. Predicting anonymous egg donor satisfaction: A preliminary study. Journal of Women’s Health 7(2):229-237. Klock, S. C., J. E. Stout, and M. Davidson. 2003. Psychological characteristics and factors related to willingness to donate again among anonymous oocyte donors. Fertility and Sterility 79(6):1312-1316. Lagasse, R. S. 2002. Anesthesia safety: Model or myth? A review of the published literature and analysis of current original data. Anesthesiology 97(6):1609-1617. Lavoir, M. C., J. Weier, J. Conaghan, and R. A. Pedersen. 2005. Poor development of human nuclear transfer embryos using failed fertilized oocytes. Reproductive BioMedicine Online 11(6):740-744. Lessor, R., N. Cervantes, N. O’Connor, J. Balmaceda, and R. H. Asch. 1993. An analysis of social and psychological characteristics of women volunteering to become oocyte donors. Fertility and Sterility 59(1):65-71. Ludwig, A. K., M. Glawatz, G. Griesinger, K. Diedrich, and M. Ludwig. 2006. Perioperative and post-operative complications of transvaginal ultrasound-guided oocyte retrieval: Prospective study of >1000 oocyte retrievals. Human Reproduction 21(12):3235-3240. Marina, S., R. Expósito, F. Marina, J. Nadal, M. Masramón, and A. Vergés. 1999. Oocyte donor selection from 554 candidates. Human Reproduction 14(11):2770-2776.

OCR for page 61
Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report Mashiach, S., D. Bider, O. Moran, M. Goldenberg, and Z. Ben-Rafael. 1990. Adnexal torsion of hyperstimulated ovaries in pregnancies after gonadotropin therapy. Fertility and Sterility 53(1):76-80. McGee, E. A., and A. J. W. Hsueh. 2000. Initial and cyclic recruitment of ovarian follicles. Endocrine Reviews 21(2):200-214. Miller, P. B., T. Price, J. E. Nichols Jr., and L. Hill. 2002. Acute ureteral obstruction following transvaginal oocyte retrieval for IVF. Human Reproduction 17(1):137-138. Ness, R. B., D. W. Cramer, M. T. Goodman, S. K. Kjaer, K. Mallin, B. J. Mosgaard, D. M. Purdie, H. A. Risch, R. Vergona, and A. H. Wu. 2002. Infertility, fertility drugs, and ovarian cancer: A pooled analysis of case-control studies. American Journal of Epidemiology 155(3):217-224. Partrick, M., A. L. Smith, W. R. Meyer, and R. A. Bashford. 2001. Anonymous oocyte donation: A follow-up questionnaire. Fertility and Sterility 75(5):1034-1036. Practice Committee of the American Society for Reproductive Medicine. 2004. Repetitive oocyte donation. Fertility and Sterility 82(SUPPL. 1): S158-S159. Rizk, B., and M. Aboulghar. 1991. Modern management of ovarian hyperstimulation syndrome. Human Reproduction 6(8):1082-1087. Rjosk, H. K., H. Haeske-Seeberg, B. Seeberg, and E. Kreuzer. 1995. IVF and GIFT—Ergebnisse in Deutschland 1993. Fertilität 11:48-54. Rosenberg, H., and Y. Epstein. 1995. Follow-up study of anonymous ovum donors. Human Reproduction 10(10):2741-2747. Salhab, M., W. Al Sarakbi, and K. Mokbel. 2005. In vitro fertilization and breast cancer risk: A review. International Journal of Fertility and Women’s Medicine 50(6):259-266. Sauer, M. V. 1996. Laparoscopy after multiple follicle aspirations fails to demonstrate pathology in oocyte donors. Journal of Assisted Reproduction and Genetics 13(5):450-452. ———. 2001. Defining the incidence of serious complications experienced by oocyte donors: A review of 1000 cases. American Journal of Obstetrics and Gynecology 184(3):277-278. Sauer, M. V., and R. J. Paulson. 1992. Oocyte donors: A demographic analysis of women at the University of Southern California. Human Reproduction 7(5):726-728. Schenker, J. G., and Y. Ezra. 1994. Complications of assisted reproductive techniques. Fertility and Sterility 61(3):411-22. Schover, L. R., R. L. Collins, M. M. Quigley, J. Blankstein, and G. Kanoti. 1991. Psychological follow-up of women evaluated as oocyte donors. Human Reproduction 6(10):1487-1491.

OCR for page 61
Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report Schover, L. R., J. Reis, R. L. Collins, J. Blankstein, G. Kanoti, and M. M. Quigley. 1990. The psychological evaluation of oocyte donors. Journal of Psychosomatic Obstetrics and Gynaecology 11(4):299-309. Steinbrook, R. 2006. Egg donation and human embryonic stem-cell research. New England Journal of Medicine 354(4):324-326. Tsen, L. C., and D. L. Hepner. 2006. Needles used for spinal anesthesia. Expert Review of Medical Devices 3(4):499-508. Tsen, L. C., M. Natale, S. Datta, and S. Eappen. 2001. Can estrogen influence the response to noxious stimuli? Journal of Clinical Anesthesia 13(2):118-121. Warner, M. A., S. E. Shields, and C. G. Chute. 1993. Major morbidity and mortality within 1 month of ambulatory surgery and anesthesia. Journal of the American Medical Association 270(12):1437-1441. Wu, C. L., S. M. Berenholtz, P. J. Pronovost, and L. A. Fleisher. 2002. Systematic review and analysis of postdischarge symptoms after outpatient surgery. Anesthesiology 96(4):994-1003. Zeleznik, A. J. 2004. The physiology of follicle selection. Reproductive Biology and Endocrinology [electronic resource]: RB&E 2(1):31.

OCR for page 61
Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research: Workshop Report This page intentionally left blank.